期刊文献+

小鼠成纤维细胞激活蛋白α二肽基肽酶核心序列原核表达与纯化及复性 被引量:4

Prokaryotic expression,purification and renaturation of catalytic domain of dipeptidyl peptidase of murine fibroblast activation protein α
原文传递
导出
摘要 目的:构建小鼠成纤维细胞激活蛋白α(FAPα)二肽基肽酶催化核心序列(FAPαc)的高效原核表达载体,进行该序列的原核表达、纯化和复性,为下一步高效抗体制作和以FAPα为靶标的抗肿瘤疫苗研发提供实验基础。方法:用PCR技术,从质粒pSecTag2/Hy-groB-FAPα中扩增出编码FAPα二肽基肽酶催化核心区域的基因片段,与原核表达载体pET28α(+)连接,在BL21(DE3)工程菌中实现重组蛋白His6-FAPαc的表达,并进行纯化和复性。结果:成功构建了小鼠来源的FAPα二肽基肽酶催化核心区域的原核表达质粒,通过对转化该质粒后的感受态细菌进行菌液PCR鉴定以及对该质粒进行BamHI和XhoI双酶切鉴定,鉴定结果与预期结果完全一致;实现了对该质粒编码的融合蛋白His6-FAPαc的表达,表达后的融合蛋白主要以包涵体的形式存在,表达产量占菌体总蛋白>70%;纯化了该融合蛋白,纯化后的蛋白纯度通过灰度分析>99%;对该融合蛋白进行了复性,复性后该融合蛋白由不溶的包涵体状态变为可溶的水溶状态。结论:成功表达、纯化和复性了FAPα二肽酶催化核心区域FAPαc,为深入开展FAPα的研究奠定基础。 OBJECTIVE: To construct a prokaryotic expression plasmid of the main catalytic domain of dipeptidyl peptidase of murine fibroblast activation protein a (FAPαc) and obtain the target fusion protein in order to provide basis for production of antibodies and anti-tumor vaccine targeting FAPα. METHODS: The gene fragment encoding catalytic domain of dipeptidyl peptidase of FAPα was amplified from plasmid pSecTag2/HygroB-FAPα by PCR and cloned into pET28α(+) vector, the recombinant protein His6-FAPαc was expressed in BL21(DE3) engineering bacteria, then the target fusion protein was purified and renatured. RESULTS:The prokaryotic expression plasmid in the catalytic domain of dipeptidyl peptidase of FAPα was successfully constructed, and the results identified by PCR and digested by BamH Ⅰ and Xho Ⅰ corresponded exactly well as expected. The fusion protein His6-FAPαc was expressed and mainly existed in the form of inclusion body. His6- FAPαc took more than 70% of the bacterial protein. The fusion protein was purified, the purity reached more than 990% through the gray-scale analysis. The fusion protein was renatured, and after being renatured, the fusion protein came into a state of the water soluble from the insoluble inclusion bodies. CONCLUSION: The catalytic domain of dipeptidy Ⅰ peptidase of FAPα is expressed, purified and renatured successfully, establishing a foundation of further research of FAPα.
出处 《中华肿瘤防治杂志》 CAS 2009年第16期1206-1209,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30873032) 国家自然科学基金(30672510) 广东省科技计划项目(2007B030704007)
关键词 成纤维细胞激活蛋白α 原核表达 纯化 复性 fibroblast activation protein α prokaryotie expression purification renaturation
  • 相关文献

参考文献11

  • 1Mueller M M, Fusenig N E. Friends or foes-bipolar effects of the tumour stroma in cancer[J]. Nature Reviews, 2004, 4(11) : 839- 849. 被引量:1
  • 2Chen W T, Kelly T. Seprase complexes in cellular invasiveness [J]. Cancer Metastasis Reviews, 2003, 22(2 -3):259 -269. 被引量:1
  • 3Ghersi G, Dong H, Goldstein L A, et al. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex[J]. J Biol Chem, 2002, 277(32): 29231-29241. 被引量:1
  • 4Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan,fluorouracil, and leucovorin for metastatic color eetalcancer[J]. N Engl J Med, 2004, 350(23): 2335 -2342. 被引量:1
  • 5Cheng J D, Weiner L M. Tumors and their microenvironments: tilling the soil[J].Clin Cancer Res, 2003, 9(5) : 1590-1595. 被引量:1
  • 6Cheng J D, Valianou M, Canutescu A A, et al. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth[J]. Mol Cancer Ther, 2005, 4(3): 351-360. 被引量:1
  • 7Loeffler M, Kruger J A, Niethammer A G, et al. Targeting tumorassociated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake[J]. J Clin Invest, 2006, 116 (7): 1955- 1962. 被引量:1
  • 8Cohen M H, Gootenberg J, Keegan P, et al. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer[J]. Oncologist, 2007, 12(3) : 356-361. 被引量:1
  • 9Giusti R M, Shastri K A, Cohen M H, et al. FDA drug approval summary: panitumumab (Vectibix)[J]. Oncologist, 2007, 12(5):577-583. 被引量:1
  • 10Hudis C A. Trastuzumab-mechanism of action and use in clinical practice[J]. N Engl J Med,2007, 357(1): 39-51. 被引量:1

同被引文献49

  • 1温秋婷,孙玉荣,李春红,刘鸿宇,柏青杨.成纤维细胞激活蛋白对卵巢癌细胞增殖、迁徙和侵袭的影响[J].中国癌症杂志,2011,21(6):441-445. 被引量:5
  • 2Iwasa S, Okada K, Chen WT, et al. Increased expression of se prase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer[J]. Cancer Lett, 2005,227(2):229-236. 被引量:1
  • 3Horak E, Smith K, Bromley L, et al. Mutant p53 EGF receptor and c-erbB-2 expression in human breast caneer[J]. Oneogene, 1991,6(12) :2277-2284. 被引量:1
  • 4Cooke T, Reeves J, Lannigan A, et al. The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker[J]. Eur J Cancer, 2001, 37(1): 3-10. 被引量:1
  • 5Ding SL, Shen LF, Yu JC, et al. Expression of estrogen receptor-alpha and Ki-67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma [J]. J Biomed Sci,2004,11(6) :911-916. 被引量:1
  • 6Bhatavdekar JM,Patel DD, Shah NG, et al. Prognostic significance of immunohisto -chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis[J]. Ann Surg Oncol, 2000,7(4):305-311. 被引量:1
  • 7Cheang MC, Chia SK, Voduc D, et al. Ki-67 index, HER2 status, and prognosis of patients with luminal B breast cancer [J]. Natl Cancer Inst, 2009, 101(10):736-750. 被引量:1
  • 8Kellermann MG,Sobral LM,da Silva SD,et al.Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis[J].Histopathology,2007,51(6):849-853. 被引量:1
  • 9Mueller MM,Fusenig NE.Friends or foes-bipolar effects of the tumour stroma in cancer[J].Nature Rev,2004,4(11):839-849. 被引量:1
  • 10Verghese ET,Shenoy H,Cookson VJ,et al.Epithelial-mesenchymal interactions in breast cancer:evidence for a role of nuclear localized beta-catenin in carcinoma-associated fibroblasts[J].Histopathology,2011,59(4):609-618. 被引量:1

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部